Karen Quinn is a seasoned pharmaceutical regulatory affairs executive with more than 35 years in the pharmaceutical industry, including over 20 years in senior global regulatory leadership roles. She has a PhD in Analytical Medicinal Chemistry and currently serves as Chief Regulatory Officer at InsuLife AS.

Her career includes senior regulatory and CMC strategy positions at Takeda, Wyeth, Millennium, Solvay, Procter & Gamble, and Dow Pharmaceuticals, as well as consulting leadership through Pharmaceutical CMC Consulting, LLC. 

Karen is widely respected for her strategic governance, ability to navigate multinational regulatory frameworks, and oversight of global submissions and approvals.